# FDA Warning Letter: Sarfez Pharmaceuticals, Inc.
> 2025-05-20 · The Office of Prescription Drug Promotion (OPDP) · `0201bf9e10f8a1b5`
## Letter
- **Company:** Sarfez Pharmaceuticals, Inc.
- **Posted Date:** 2025-05-20
- **Letter Issue Date:** 2025-04-25
- **Issuing Office:** The Office of Prescription Drug Promotion (OPDP)
## Subject
False & Misleading Claims/Misbranded
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*